165. Deputy Claire Kerrane asked the Minister for Health if patients with Duchenne muscular dystrophy will have access to the early access programme for givinostat; and if she will make a statement on the matter. [33077/25]
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
Showing questions under the heading Medicinal Products.
1,228 questions match, newest first.
167. Deputy Roderic O'Gorman asked the Minister for Health to provide an update on the health technology assessment being carried out on the orphan medicine givinostat (brand name duvyzat) used to treat Duchenne muscular dystrophy; if there are any steps she can take to speed up the assessment process; and if she will make a statement on the matter. [33092/25]
741. Deputy Cathal Crowe asked the Minister for Health when the medication known as givinostat will be made available in Ireland, given its potential role in the treatment of Duchenne muscular dystrophy; and if she will make a statement on the matter. [31801/25]
746. Deputy Richard Boyd Barrett asked the Minister for Health whether she will intervene to ensure that a person (details supplied) with Duchenne muscular dystrophy can be prescribed givnostat as a matter of urgency. [31826/25]
747. Deputy Michael Healy-Rae asked the Minister for Health if the drug givinostat will be approved in Ireland (details supplied); and if she will make a statement on the matter. [31827/25]
759. Deputy Erin McGreehan asked the Minister for Health if she will provide details regarding the prescribing of antidepressants to patients who are covered under the medical card scheme and the drugs payment scheme; and if she will make a statement on the matter. [31852/25]
773. Deputy John Brady asked the Minister for Health if she will make the drug givinostat available to all who are diagnosed with Duchenne Muscular Dystrophy; if so, whether she will provide a timeline for the rollout of this drug; and if she will make a statement on the matter. [31934/25]
807. Deputy Shane Moynihan asked the Minister for Health when medication known as givinostat will be made available in the State, given the role it can play in treating Duchenne muscular dystrophy in young boys. [32084/25]
827. Deputy Seán Canney asked the Minister for Health if she will expedite the process of approval for givinostat, used in the treatment of Duchenne Muscular Dystrophy, as further delays could affect the ability of patients to retain muscular strength and the current process for drug approval in Ireland can take on average 617 days, during which time muscular dystrophy patients will have lost significant muscle stren…
833. Deputy Cian O'Callaghan asked the Minister for Health if she will ensure that a new medication (details supplied) is processed on the HSE reimbursement list as quickly as possible when it is given EU approval; if she will take action to make this medication available for all children with Duchenne Muscular Dystrophy; and if she will make a statement on the matter. [32302/25]
858. Deputy Barry Ward asked the Minister for Health if her attention has been drawn to the concerns of pharmacists regarding the prohibitive cost of the shingles vaccine, despite it being recommended by the National Immunisation Advisory Committee; if her Department has engaged with the manufacturer in any way to seek a reduction in price per unit; and if she will make a statement on the matter. [32385/25]
861. Deputy Ged Nash asked the Minister for Health if she is aware of the issues Duchenne muscular dystrophy patients are having getting timey access to a new drug for the condition (details supplied); if immediate steps will be taken to make this drug available; and if she will make a statement on the matter. [32396/25]
870. Deputy Cormac Devlin asked the Minister for Health the status of consideration, use (even on a trial basis), and funding for the drug givinostat for Duchenne muscular dystrophy; and if she will make a statement on the matter. [32461/25]
882. Deputy Paul Donnelly asked the Minister for Health if there are plans to further roll out the free HRT scheme to men and others who use HRT for medical reasons. [32518/25]
885. Deputy Liam Quaide asked the Minister for Health her plans to make eylea or aflibercept, available to suitable patients in Irish hospitals for the treatment of the wet form of age-related macular degeneration; and if she will make a statement on the matter. [32555/25]
923. Deputy Darren O'Rourke asked the Minister for Health if she is considering an early access programme to givinostat (details supplied) for Duchenne muscular dystrophy patients in Ireland, similar to that provided in Scotland; and if she will make a statement on the matter. [32733/25]
924. Deputy Darren O'Rourke asked the Minister for Health if she is considering providing access to fivinostat for non-ambulant Duchenne muscular dystrophy patients in Ireland in addition to ambulant patients; and if she will make a statement on the matter. [32734/25]
931. Deputy Pádraig Rice asked the Minister for Health the steps she will take to ensure that adults with spinal muscular atrophy receive access to approved medicines (details supplied); if she will engage in dialogue with stakeholders regarding the current age-based exclusion; and if she will make a statement on the matter. [32774/25]
939. Deputy Eoghan Kenny asked the Minister for Health if she has given consideration to a fast-tracked review of vyloy for inclusion in the HSE reimbursement scheme; and if she will make a statement on the matter. [32811/25]
940. Deputy Ryan O'Meara asked the Minister for Health if the drug, victoza, also known as liraglutide, is available under the drugs payment scheme (DPS) for patients who have had it prescribed for weight loss; if not, whether there are alternatives available under the DPS that a patient may instead discuss with their GP; and if she will make a statement on the matter. [32817/25]
502. Deputy Mairéad Farrell asked the Minister for Health if the approval of a drug will be expedited considering its urgent need by a person (details supplied). [31405/25]
534. Deputy Conor Sheehan asked the Minister for Health if she will examine and expedite the approval of a new drug givinostat which has been approved in the UK and US for the treatment of Duchenne muscular dystrophy; and if she will make a statement on the matter. [31509/25]
542. Deputy Liam Quaide asked the Minister for Health her plans to expedite the national assessment and decision process for the use of duvyzat (givinostat) to treat patients with Duchenne muscular dystrophy; and if she will make a statement on the matter. [31557/25]
1352. Deputy Albert Dolan asked the Minister for Health the rationale for excluding evorel 100mcg patches from the new hormone replacement therapy (HRT) scheme, given its widespread use as a substitute for estradot, which has been in long-term short supply; the measures being taken to ensure continuity of HRT care for those impacted by the supply shortages of estradot, including the potential inclusion of alternative…
1380. Deputy Louis O'Hara asked the Minister for Health the reason evorel patches, which are being dispensed in place of estradot due to an ongoing shortage, are not covered under the new free hormone replacement therapy scheme; and if she will make a statement on the matter. [29459/25]